Evidence map›Paper›PMID 37869733›Full record

ArticleWellcome open research2023

Development of a point-of-care genetic test for effective treatment of ischaemic stroke: an early model-based cost-effectiveness analysis.

Stuart Wright, John McDermott, Dwaipayan Sen, Craig Smith, William Newman, Katherine Payne

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Wellcome open research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 3 pooled it
2.0field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 3 syntheses or guidelines pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Stuart WrightManchester Centre for Health Economics, The University of Manchester, Manchester, M139PL, UK.ORCID https://orcid.org/0000-0002-4064-7998
John McDermottManchester Centre for Genomic Medicine, The University of Manchester, Manchester, M13 9PL, UK.
Dwaipayan SenGreater Manchester Comprehensive Stroke Centre, Geoffrey Jefferson Brain Research Centre, Salford Royal Foundation Trust, Salford, M6 8HD, UK.
Craig SmithGreater Manchester Comprehensive Stroke Centre, Geoffrey Jefferson Brain Research Centre, Salford Royal Foundation Trust, Salford, M6 8HD, UK.
William NewmanManchester Centre for Genomic Medicine, The University of Manchester, Manchester, M13 9PL, UK.
Katherine PayneManchester Centre for Health Economics, The University of Manchester, Manchester, M139PL, UK.ORCID https://orcid.org/0000-0002-3938-4350
Manchester Academic Health Science Centre · GBSalford Royal NHS Foundation Trust · GBUniversity of Manchester · GB

Funding

Wellcome Trust
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Clopidogrelcost-effectiveness analysisearly health technology assessment.Economic evaluationPharmacogeneticsPrecision medicineStroke

Identifiers

PMID37869733
PMCPMC10587658
OpenAlexW4366823894

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.